Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 8924 | 1136 | 46.4 | 89% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 88 | 25697 | ULCERATIVE COLITIS//CROHNS DISEASE//INFLAMMATORY BOWEL DISEASE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | DEXTRAN SULFATE SODIUM | Author keyword | 12 | 21% | 4% | 50 |
| 2 | EXPERIMENTAL COLITIS | Author keyword | 7 | 15% | 4% | 42 |
| 3 | BIOL CHEM BIOACT | Address | 4 | 75% | 0% | 3 |
| 4 | GI BIOL DIS | Address | 4 | 50% | 1% | 6 |
| 5 | IL10 MICE | Author keyword | 3 | 57% | 0% | 4 |
| 6 | DSS INDUCED COLITIS | Author keyword | 3 | 26% | 1% | 11 |
| 7 | MUCOSAL IMMUN SECT | Address | 3 | 13% | 2% | 22 |
| 8 | DEXTRAN SULPHATE SODIUM | Author keyword | 2 | 22% | 1% | 10 |
| 9 | DEXTRAN SODIUM SULFATE DSS | Author keyword | 2 | 38% | 0% | 5 |
| 10 | DEXTRAN SODIUM SULFATE | Author keyword | 2 | 15% | 1% | 14 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | DEXTRAN SULFATE SODIUM | 12 | 21% | 4% | 50 | Search DEXTRAN+SULFATE+SODIUM | Search DEXTRAN+SULFATE+SODIUM |
| 2 | EXPERIMENTAL COLITIS | 7 | 15% | 4% | 42 | Search EXPERIMENTAL+COLITIS | Search EXPERIMENTAL+COLITIS |
| 3 | IL10 MICE | 3 | 57% | 0% | 4 | Search IL10++++MICE | Search IL10++++MICE |
| 4 | DSS INDUCED COLITIS | 3 | 26% | 1% | 11 | Search DSS+INDUCED+COLITIS | Search DSS+INDUCED+COLITIS |
| 5 | DEXTRAN SULPHATE SODIUM | 2 | 22% | 1% | 10 | Search DEXTRAN+SULPHATE+SODIUM | Search DEXTRAN+SULPHATE+SODIUM |
| 6 | DEXTRAN SODIUM SULFATE DSS | 2 | 38% | 0% | 5 | Search DEXTRAN+SODIUM+SULFATE+DSS | Search DEXTRAN+SODIUM+SULFATE+DSS |
| 7 | DEXTRAN SODIUM SULFATE | 2 | 15% | 1% | 14 | Search DEXTRAN+SODIUM+SULFATE | Search DEXTRAN+SODIUM+SULFATE |
| 8 | ANTI IL 12P40 | 2 | 67% | 0% | 2 | Search ANTI+IL+12P40 | Search ANTI+IL+12P40 |
| 9 | IL 10 THERAPY | 2 | 67% | 0% | 2 | Search IL+10+THERAPY | Search IL+10+THERAPY |
| 10 | INTERLEUKIN 10 DEFICIENT MICE | 2 | 67% | 0% | 2 | Search INTERLEUKIN+10+DEFICIENT+MICE | Search INTERLEUKIN+10+DEFICIENT+MICE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTERLEUKIN 10 DEFICIENT MICE | 25 | 23% | 9% | 99 |
| 2 | CHRONIC INTESTINAL INFLAMMATION | 24 | 30% | 6% | 66 |
| 3 | ALPHA MUTANT MICE | 18 | 39% | 3% | 36 |
| 4 | MURINE COLITIS | 14 | 18% | 6% | 67 |
| 5 | DEXTRAN SULFATE SODIUM | 12 | 15% | 6% | 69 |
| 6 | RESIDENT INTESTINAL FLORA | 11 | 31% | 3% | 29 |
| 7 | NORMAL LUMINAL BACTERIA | 10 | 52% | 1% | 13 |
| 8 | ESTABLISHED EXPERIMENTAL COLITIS | 9 | 31% | 2% | 24 |
| 9 | IL 10 DEFICIENT MICE | 9 | 27% | 2% | 27 |
| 10 | G ALPHA I2 DEFICIENT MICE | 8 | 70% | 1% | 7 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The immunology of mucosal models of inflammation | 2002 | 778 | 169 | 43% |
| Dextran Sodium Sulphate Colitis Mouse Model: Traps and Tricks | 2012 | 65 | 60 | 43% |
| The immunological and genetic basis of inflammatory bowel disease | 2003 | 914 | 125 | 26% |
| Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis | 2006 | 543 | 120 | 20% |
| T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade | 2009 | 87 | 28 | 43% |
| Role of cytokines in the pathogenesis of inflammatory bowel disease | 2000 | 354 | 20 | 40% |
| Animal models of mucosal inflammation and their relation to human inflammatory bowel disease | 1999 | 314 | 50 | 50% |
| Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota | 2005 | 261 | 139 | 35% |
| Animal models of inflammatory bowel disease: a review | 2014 | 6 | 99 | 29% |
| Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease | 2015 | 1 | 109 | 27% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOL CHEM BIOACT | 4 | 75% | 0.3% | 3 |
| 2 | GI BIOL DIS | 4 | 50% | 0.5% | 6 |
| 3 | MUCOSAL IMMUN SECT | 3 | 13% | 1.9% | 22 |
| 4 | GI BIOL | 2 | 43% | 0.3% | 3 |
| 5 | FOOD TEXT GRP | 2 | 22% | 0.5% | 6 |
| 6 | ELSE KROENER F ENIUS | 1 | 100% | 0.2% | 2 |
| 7 | FOOD METAB MICROBIOL SECT | 1 | 18% | 0.5% | 6 |
| 8 | ANIM SCI CENT ANIM IL | 1 | 40% | 0.2% | 2 |
| 9 | ELSE KROENER F ENIUS EXPT NUTR MED | 1 | 40% | 0.2% | 2 |
| 10 | BIOINFORMAT MATH STAT SECT | 1 | 27% | 0.3% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000229860 | INTESTINAL EPITHELIAL//CRI 4U004B//LUMINAL CYTOKINES |
| 2 | 0.0000179584 | INTESTINAL FIBROSIS//SUBEPITHELIAL FIBROBLASTS//SECT BRAIN STRUCT |
| 3 | 0.0000169549 | INTESTINAL INTRAEPITHELIAL LYMPHOCYTES//INTRAEPITHELIAL LYMPHOCYTES//INTRAEPITHELIAL LYMPHOCYTE IEL |
| 4 | 0.0000163137 | ADHERENT INVASIVE E COLI//ADHERENT INVASIVE ESCHERICHIA COLI//JE2526 |
| 5 | 0.0000162690 | ACETIC ACID INDUCED COLITIS//EXPERIMENTAL COLITIS//COLONIC PERFUSION |
| 6 | 0.0000149629 | IS 741//MADCAM 1//ALPHAEBETA7 |
| 7 | 0.0000121941 | CCR9//CCL28//ANTIGEN P ENTAT GRP |
| 8 | 0.0000118965 | NOD2//CARD15//NOD1 |
| 9 | 0.0000103594 | ANTI SACCHAROMYCES CEREVISIAE ANTIBODIES//ASCA//ANTI SACCHAROMYCES CEREVISIAE ANTIBODY |
| 10 | 0.0000093981 | INFLIXIMAB//VEDOLIZUMAB//ADALIMUMAB |